WORCESTER, Mass.--(BUSINESS WIRE)--RXi Pharmaceuticals Corporation (Nasdaq: RXII), a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), today announced that Tod Woolf, Ph.D., President and Chief Executive Officer, will present a corporate overview of the Company at the Natixis Bleichroeder Second Annual Hidden Gems Conference at the Waldorf Astoria Hotel in New York City on Monday, October 13, 2008 at 11:30 AM ET.
